Connect Biopharma Holdings Limited
CNTB
$2.12
-$0.08-3.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.19% | -52.68% | -- | -34.90% | -29.00% |
| Total Receivables | 1,443.43% | -84.68% | -- | -94.58% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 333.84% | 191.83% | -- | 165.60% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -37.30% | -47.47% | -- | -32.91% | -- |
|
|
|||||
| Total Current Assets | -37.30% | -47.47% | -- | -32.91% | -- |
| Net Property, Plant & Equipment | -9.89% | 5.15% | -- | 7.90% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -14.00% | -15.09% | -- | -15.79% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,335.56% | 1,857.58% | -- | -53.13% | -- |
| Total Assets | -35.19% | -44.64% | -- | -31.39% | -- |
|
|
|||||
| Total Accounts Payable | 427.05% | 474.27% | -- | -59.76% | -- |
| Total Accrued Expenses | 70.39% | 43.04% | -- | 151.20% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.34% | 109.09% | -- | 38.89% | -- |
| Total Finance Division Other Current Liabilities | -- | 1.83% | -- | -68.03% | -- |
| Total Other Current Liabilities | -- | 1.83% | -- | -68.03% | -- |
| Total Current Liabilities | 99.01% | 60.87% | -- | 11.61% | -- |
|
|
|||||
| Total Current Liabilities | 99.01% | 60.87% | -- | 11.61% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -51.68% | 1,433.33% | -- | 612.33% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -82.30% | -81.96% | -- | -69.04% | -- |
| Total Liabilities | 78.24% | 54.58% | -- | 12.80% | -- |
|
|
|||||
| Common Stock & APIC | 5.40% | 1.10% | -- | -29.81% | -- |
| Retained Earnings | -18.17% | -16.06% | -- | 30.69% | -- |
| Treasury Stock & Other | 30.36% | 25.73% | -- | -111.70% | -- |
| Total Common Equity | -48.58% | -54.45% | -- | -35.42% | -18.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -48.58% | -54.45% | -- | -35.42% | -18.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -48.58% | -54.45% | -- | -35.42% | -18.32% |
|
|
|||||